ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Acumen Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.77+0.08 (+4.73%)
Close on Oct 19, 2026
- Market cap
- $127.88M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Acumen Pharmaceuticals has not reported a dividend
No dividend per share appears in Acumen Pharmaceuticals's annual filings since fiscal 2019.